Products

Wysa
Wysa
Clinical Decision Support & Reference
Wysa is an AI-driven platform and chatbot that provides conversational support using evidence-based therapeutic techniques and offers insights to help clinicians tailor treatment to client needs.

See all 1 product →

About Wysa

Wysa is a global leader in AI-driven mental health support, offering a platform that integrates conversational AI with human coaching to provide accessible and personalized care. For physicians, Wysa’s platform can serve as a valuable tool for extending mental health support beyond the clinic, complementing existing care without increasing clinical workload. The AI chatbot leverages evidence-based techniques such as Cognitive Behavioral Therapy (CBT), Dialectical Behavior Therapy (DBT), mindfulness exercises, and motivational interviewing to guide users through self-help tools and structured conversations.

The platform is designed to support a wide range of mental health concerns, including stress management, anxiety, depression, sleep improvement, and chronic pain. Wysa has received FDA Breakthrough Device Designation for its use in managing chronic musculoskeletal pain and related depression and anxiety, and its efficacy is backed by peer-reviewed research and clinical trials. It also includes built-in safety features to detect signs of distress, such as self-harm or suicidal thoughts, and can escalate to human therapists or local crisis helplines when appropriate. Wysa offers solutions for individuals, employers, insurers, and healthcare providers, with a focus on anonymity and security for users.

Focus Areas

AI-driven mental health support conversational AI digital therapeutics behavioral health chronic pain management stress management anxiety depression mindfulness cognitive behavioral therapy (CBT) dialectical behavior therapy (DBT) hybrid care models

Business Intelligence

TechnologyAI-powered conversational platform, cloud-based infrastructure, evidence-based cognitive-behavioral techniques (CBT), dialectical behavior therapy (DBT), natural language processing

What Physicians Need to Know

Specialization: Mental Health Support
Wysa specializes in AI-powered mental health support, offering a conversational chatbot that provides self-guided interventions for various mental health concerns, including anxiety, depression, and stress. They also address mental health impacts associated with chronic pain.
Key Differentiator: Clinically Validated AI
Wysa's AI is clinically validated with over 40 peer-reviewed studies, including randomized controlled trials and NIH-funded research programs, demonstrating its effectiveness in reducing symptoms of depression and anxiety (by 27-40%). It has received FDA Breakthrough Device Designation for its efficacy in managing chronic pain, depression, and anxiety.
Technology Stack: Conversational AI & NLP
Wysa's core technology involves AI models utilizing natural language processing (NLP), natural language understanding (NLU), machine learning, and deep learning to interpret user messages and provide empathetic, clinically safe responses. They use a combination of rule-based algorithms and large language modeling. The platform employs over 100 NLU models and a sophisticated rules engine.
Hybrid Approach: AI with Human Coaching
Wysa offers a hybrid model, combining its AI chatbot with the option to connect with human coaches or therapists, providing a blend of advanced AI tools and human support. This approach enhances patient engagement and outcomes.
Data Security & Privacy
Wysa prioritizes data privacy and security, encrypting all user data at rest and in transit using strong TLS and AES-256 encryption protocols. Their servers are hosted by industry leaders with GDPR and HIPAA-compliant security programs. Wysa does not train its AI on user conversations or sell data.
Accessibility & Scalability
Wysa aims to provide accessible mental health support to everyone, anytime, through its mobile app and web application. Its self-guided interventions can be administered to large populations at minimal cost, addressing gaps in healthcare provision, especially in underserved communities.
Integration with Care Models
Wysa integrates with existing workflows, including Electronic Health Records (EHRs), to streamline operations and reduce administrative burdens for healthcare providers. It supports Chronic Care Management (CCM), Collaborative Care Model (CoCM), and Remote Patient Monitoring (RPM) services.
Physician Tip

For physicians, Wysa offers a powerful tool to extend mental health support beyond the clinic, enabling continuous patient engagement and streamlined care coordination. The platform's clinically validated AI can assist with automated screenings, progress monitoring, and crisis detection, freeing up clinicians to focus on complex cases. Its integration capabilities with EHRs and support for models like CoCM, CCM, and RPM can reduce administrative load and potentially generate new revenue streams. Wysa's ability to provide 24/7 AI-driven self-help ensures patients receive immediate support, improving outcomes for conditions like anxiety, depression, and chronic pain. The AI can also summarize therapeutic sessions, allowing physicians to remain more present with patients.

Wysa is designed for seamless integration into existing healthcare workflows, including Electronic Health Records (EHRs), to facilitate the flow of symptom data, risk alerts, and medication adherence insights directly into clinicians' dashboards. They also support integrations for Chronic Care Management (CCM), Collaborative Care Model (CoCM), and Remote Patient Monitoring (RPM) services, aiming to reduce technical and administrative burdens.

Products by Wysa

1 product in the directory

Wysa
Wysa
Clinical Decision Support & Reference
Wysa is an AI-driven platform and chatbot that provides conversational support using evidence-based therapeutic techniques and offers insights to help clinicians tailor treatment to client needs.

What the Web Says

Wysa is an AI-powered mental health chatbot that offers CBT, DBT, ACT, and mindfulness-based interventions through a conversational interface. It's designed to help users manage stress, anxiety, emotional overwhelm, sleep issues, and daily mental health habits. The app is widely praised for its accessibility, non-judgmental environment, and evidence-based techniques, making it a solid starting point for mild to moderate mental health concerns. While it offers a free tier, some advanced features and human coaching come with a cost.

Overall: Positive

Strengths

  • Available 24/7, providing immediate support during acute moments of distress.
  • Offers a non-judgmental and private space for users to express themselves.
  • Utilizes evidence-based techniques like CBT, DBT, and mindfulness.
  • Has a useful free version that provides access to core chatbot features and some self-help tools.
  • Helps users develop coping strategies and track their mood.
  • Clinically validated with numerous peer-reviewed publications and NHS endorsement.

Limitations

  • AI responses can sometimes feel generic, repetitive, or scripted, lacking the nuance of human interaction.
  • Premium features and human coaching incur additional costs.
  • Not a substitute for a licensed therapist or crisis services for severe mental health conditions.
  • Conversational depth can be limited by pre-populated response options.
  • May misread complex emotions or miss subtle cues.
  • Self-motivation is required for self-guided tools to be effective.

Based on reviews from: Reddit, Psychology.com, Google Play, Apple App Store, JMIR mHealth and uHealth, Talkspace, Ai Insights News, Wellness AI, Shortlister, Indeed.com, G2

Last updated: 2026-09-21

Videos

News, demos, and interviews about Wysa.

Loading videos...

Videos load interactively. If none appear, search YouTube for Wysa →

View all on YouTube

Press & Coverage

Kae Capital / Business Wire
Wysa secures $20mn to address global mental health demand with AI digital Therapeutics
Wysa, an AI digital mental health platform, secured $20 million in financing to expand into the US, UK, India, and other global markets, and to improve usability through multi-lingual support and WhatsApp access. The funding round was led by HealthQuad and British International Investment (BII), with participation from earlier investors.
2022-07
Express Healthcare
Wysa receives FDA Breakthrough Device Designation for its mental health conversational agent
Wysa received FDA Breakthrough Device Designation for its AI-based digital mental health conversational agent for adults with chronic musculoskeletal pain, depression, and anxiety. The device delivers cognitive behavioral therapy (CBT) via a smartphone-based conversational agent to reduce symptoms and improve physical function.
2022-05
Wysa / Business Wire
Wellcome Trust Awards £5.3 Million Grant to Wysa
The Wellcome Trust awarded Wysa a £5.3 million grant to fund a study adapting a clinically validated digital mental health intervention for adolescent girls in rural India. This initiative aims to address significant mental health inequalities in this population.
2026-02
Endpoints News
Exclusive: Once a mental health chatbot, Wysa acquires physical therapy startup Kins
Wysa, an AI mental health platform, acquired physical therapy startup Kins in an all-stock deal. This acquisition is part of Wysa's strategy to expand beyond its mental health app and integrate AI more deeply into healthcare delivery, particularly for at-home care.
2025-09
Wysa News
Wysa Launches AI-Powered Chatbot to Streamline Mental Health Patient Intake in the US
Wysa launched Wysa Gateway, an AI-powered chatbot designed to streamline patient intake for therapy providers and health plans in the US. This chatbot automates clinical screenings, aiming to provide faster, more accurate, and personalized access to therapy.
2025-06
Business Wire
Wysa Partners with RxCap to Advance Medication Adherence
Wysa announced a strategic partnership with RxCap, a provider of remote monitoring solutions for medication adherence. This collaboration integrates RxCap's technology into Wysa's care platform, offering real-time insights into medication adherence to improve patient outcomes.
2025-06
HLTH
April Health and Wysa Merge to Transform Behavioral Healthcare Access
April Health and Wysa merged to address the mental health crisis by combining human-led care with Wysa's AI. The new entity aims to embed behavioral health into primary care, providing continuous support and reducing wait times.
2025-03
The National Law Review
Wysa Launches Multilingual Capabilities to Broaden Access to Mental Health Support Globally
Wysa expanded its clinically validated digital mental health support to include six new languages: French, German, Italian, Arabic, Japanese, and Brazilian Portuguese. This expansion builds on existing support for English, Spanish, and Hindi, enabling Wysa to serve a truly global user base.
2025-12

Frequently Asked Questions

Wysa offers an AI-powered conversational agent, often called the 'Pocket Penguin Coach,' which provides 24/7 mental health support using techniques like CBT, DBT, and mindfulness. For healthcare providers, Wysa Copilot is designed to integrate structured AI support with human connection, helping care teams personalize support, assign tools, and keep patients engaged between sessions. Wysa's AI-led mental health conversational agent has received FDA Breakthrough Device Designation for adults with chronic musculoskeletal pain and associated depression and anxiety, following a peer-reviewed clinical trial. The company also has over 45 peer-reviewed publications demonstrating its efficacy across various clinical concerns.
Wysa prioritizes anonymity and minimizes personal data collection, with no registration needed for the app. They are compliant with GDPR and HIPAA through stringent security programs and controls with their cloud hosting partners. Wysa's information security management system (ISMS) and privacy information management system (PIMS) are audited and certified for ISO 27001 and ISO 27701. All data is encrypted using strong TLS and AES-256 encryption protocols during transmission and storage.
Wysa offers custom pricing for enterprise and employer solutions. While individual premium self-care subscriptions are around $74.99 annually and human coaching starts at $19.99 per session, these are typically for direct-to-consumer use. For healthcare providers, Wysa's Chronic Care Management (CCM) service can offer a new revenue stream and is bundled with 24/7 digital self-help, with no upfront cost to the provider or patient.
Wysa aims for seamless integration into existing practice workflows, offering a 'done for you' program that manages administrative tasks for providers. Their Copilot solution helps clinicians manage larger caseloads, reduces administrative burden through automated workflows, and provides secure messaging for continuity of care. Wysa's clinical support team also handles routine care coordination and patient follow-ups, allowing physicians to focus on clinical expertise.
Wysa has established partnerships with various institutions, including employers, insurance companies like Vitality, and healthcare providers such as MyCHN and April Health. These collaborations aim to integrate Wysa's AI into existing care models, expand access to mental health support, and offer solutions like Chronic Care Management (CCM), Remote Therapeutic Monitoring (RTM), and Remote Patient Monitoring (RPM) that can generate revenue for providers.
Wysa is a Series B company that has raised a total of $30.5 million in funding across 11 rounds, with its latest funding round in February 2026. Investors include HealthQuad, British International Investment (BII), W Health Ventures, Kae Capital, Google Assistant Investments, and pi Ventures. The company has a global presence, supporting over 7 million users across 95 countries, and continues to expand into various markets.
Wysa's AI continuously screens for signs of distress and has crisis detection (SOS) features. When a user expresses thoughts of self-harm or suicide, the AI gently guides them towards human help, such as in-app escalation or local helplines, rather than attempting to 'solve' the crisis with AI. All high-risk incidents are logged and shared with care teams for appropriate follow-up. Wysa's support interventions and clinical flows are meticulously crafted by experienced clinicians and psychologists.

Investors

Who's funded Wysa.

Related Companies

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]

The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]

TimeDoc Health is a healthcare technology and services company that provides virtual care management solutions, primarily focusing on chronic care management (CCM), remote patient monitoring (RPM), and behavioral health integration (BHI). Their platform and services are designed to help healthcare organizations, including primary care providers, health systems, FQHCs (Federally Qualified Health Centers), and Medicare Advantage […]

Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]

PMHScribe is an AI-powered clinical documentation tool specifically designed for psychiatrists, Psychiatric Mental Health Nurse Practitioners (PMHNPs), therapists, and other behavioral health clinicians. Unlike generic AI scribes, PMHScribe is built to understand the unique workflows and documentation requirements of mental healthcare, generating structured notes such as SOAP, DAP, and BIRP notes. The platform aims to […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.